The continuation of the Prevention of Events With Angiotensin-Converting Enzyme Inhibition (PEACE) Trial - 03/09/11
Doi : 10.1067/mhj.2001.117603
Marc A. Pfeffer, MD, PhDa, Michael Domanski, MDc, Joel Verter, PhDd, Mark Dunlap, MDe, Greg C. Flaker, MDf, Bernard Gersh, MB, ChB, DPhilg, Judith Hsia, MDd, A.David Goldberg, MDh, Marian C. Limacher, MDi, Aldo P. Maggioni, MDj, Yves Rosenberg, MDc, Jean-Lucien Rouleau, MDk, J.Wayne Warnica, MDl, Alan G. Wasserman, MDd, Eugene Braunwald, MDb
for the PEACE Investigators
Boston, Mass, Bethesda and Rockville, Md, Cleveland, Ohio, Columbia, Mo, Rochester, Minn, Detroit, Mich, Gainesville, Fla, Florence, Italy, and Toronto, Ontario, and Calgary, Alberta, Canada
From the aCardiovascular Division, Brigham and Women’s Hospital, and bPartners HealthCare System, Boston, Mass, the cClinical Trials Group, National Heart, Lung, and Blood Institute, Bethesda, and the dBiostatistics Center and Cardiovascular Division, George Washington University, Rockville, Md, the eCleveland Veterans Administration Medical Center, Cleveland, Ohio, the fUniversity of Missouri, Columbia, Mo, the gCardiovascular Division, Mayo Clinic, Rochester, Minn, the hHenry Ford Hospital, Detroit, Mich, the iGainesville Veterans Administration Medical Center, Gainesville, Fla, the jANMCO Research Center, Florence, Italy, the kToronto General Hospital, Toronto, Ontario, and the lFoothills Hospital, Calgary, Alberta, Canada
| ☆ | Reprint requests: Marc A. Pfeffer, MD, PhD, Cardiovascular Division, Brigham and Women’s Hospital, 75 Francis St, Boston, MA 02115. E-mail: mpfeffer@rics.bwh.harvard.edu |
| ☆☆ | Am Heart J 2001;142:375-7. |
© 2001
Mosby, Inc. Tous droits réservés.
Vol 142 - N° 3
P. 375-377 - septembre 2001 Retour au numéro
Article précédent
- Blockade of adenosine receptors with aminophylline limits ischemic preconditioning in human beings
- Saul Schaefer, Steven D. Correa, Richard J. Valente, Lawrence J. Laslett
- Stent selection in clinical practice: Have clinical trials provided the evidence we need?
- Jeffrey J. Popma
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?